Above normal monsoon forecast and strength in Asian equities lifted sentiments.
The sharp fall in the rupee's value against the dollar during the July-September quarter, it turns out, has come as a boon for corporate earnings.
India Inc will report good set of numbers in Q4.
Nifty50 surged 145 points to close at 8,468 after hitting an intra-day high of 8,475.
The 30 share Sensex ended up 183 points at 27,470 and the 50-share Nifty gained 44 points to close at 8,295.
Broader markets outperformed with BSE Midcap and BSE Smallcap adding 0.23% and 0.45%, respectively
Jonathan Garner, chief Asia and emerging markets equity strategist, Morgan Stanley, gives Samie Modak his assessment of the Indian economy after 3 years of Modi Sarkar.
Investors will maintain a cautious stance.
Sources indicated defence and national security initiatives.
Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company ChairmanIsrael Makov said.
The Sensex closed down 308 points at 24,894 and the Nifty has lost 96 points at 7,559.
After a volatile session, Sensex closed the day 563 points lower
Why India is an FDI magnet. The country satisfies several reconditions to attract FDI.
Telecom stocks fell after Mukesh Ambani extended Reliance Jio's free offers till March 2017.
Chinese President Xi Jinping pledged on Thursday to give Indian companies and products - especially including those made by the pharmaceutical, farming and fuel industries - greater access to Chinese markets.
The 30-share Sensex surged 299 points to close at 28,736 and the 50-share Nifty gained 90 points to end at 8,723.
The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products
Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.
Prime minister likely to visit Beijing, Shanghai; also President Xi's home province, Shaanxi. Nayanima Basu reports
There isn't much Budget could do directly to help sectors.
On his recent visit to China, the President made eminently sensible suggestions to improve relations except that they can't work in the present atmosphere.
This analysis is based on the quarterly earnings for 724 companies.
The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,543.
A slow but steady economic uptick can be seen in various segments of the economy. India's economy expanded 4.8 per cent in the second quarter, higher than the preceding quarter's 4.4 per cent.
Another year of strong performance by these export-oriented sectors likely as US economy revives and rupee is expected to be under pressure.
Cashi Crisis: Day 9: Aaj ki Taaza Khabar!
Profits grow, but not because of recovering demand.
The US president's four-day tour will feature talks with British PM Theresa May, tea with the Queen, and mass protests including a giant Trump baby blimp being flown over Westminster.
While some companies used that to become world leaders, others squandered it by over-borrowing.
The top gainers on the Sensex were Cipla, Bharti Airtel, Maruti Suzuki, Hero Moto & Sesa Sterlite.
Sensex rises, Nifty holds 8,900; FMCG, Pharma shares lead.
Recently, The World Bank has come up with the latest figures on the wealthiest countries in the world.
Investors will remain cautious ahead of F&O expiry.
India Ic has pulled up its socks to perform even better in FY16.
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
Through the past 12 months, the Bank Nifty has risen 55%
Nifty50 surged 87 points to end at 8,157, highest closing levels since Oct 29, 2015.
Large and small businesses alike have delivered low-key performances.
Analysts now expect India Inc to report a decline in both top line and bottom line for the September quarter.
Sensex, Nifty put up a good show in closing trade.
